JXL082, or JXL-082, is a drug acting as a mitochondrial pyruvate carrier (MPC) inhibitor which was synthesized towards the aim of developing a treatment for hair loss. It is related to other drugs in the same series such as suvomipic (PP405; JXL069) and UK-5099 (JXL001). The drug is known to have been sold online in a grey market fashion for treatment of hair loss. It has been mistakenly believed to be suvomipic in the past. JXL082 was first described in the scientific literature by 2019.
See also List of investigational hair loss drugs Suvomipic (PP405; JXL069) UK-5099 (JXL001)
References